How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action

• Main Authors: Rosanne Janssens (Author), Liese Barbier (Author), Mireille Muller (Author), Irina Cleemput (Author), Isabelle Stoeckert (Author), Chiara Whichello (Author), Bennett Levitan (Author), Tarek A. Hammad (Author), Charis Girvalaki (Author), Juan-Jose Ventura (Author), Karin Schölin Bywall (Author), Cathy Anne Pinto (Author), Elise Schoefs (Author), Eva G. Katz (Author), Ulrik Kihlbom (Author), Isabelle Huys (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: Patients have unique insights and are (in-)directly affected by each decision taken throughout the life cycle of medicinal products. Patient preference studies (PPS) assess what matters most to patients, how much, and what trade-offs patients are willing to make. IMI PREFER was a six-year...